Research and Markets: Global Calcium Channel Antagonists (Migraine) Forecasts and Opportunities to 2023


Research and Markets ( has announced the addition of the “Calcium Channel Antagonists (Migraine) – Forecast and Market Analysis to 2023″ report to their offering.

By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

Calcium channel antagonists initially evoked interest in the treatment of migraine due to their vasodilator effects on the cerebral vasculature (Montastruc and Senard, 1992). However, their effects are most likely due to blocking the transmembrane influx of calcium across cell membranes through slow, voltage-dependent channels. Calcium channels are located extracellularly or intracellularly and consist of different subtypes: those that are voltage-gated (opened by depolarization) and ligand-gated (opened by chemical messengers).


– Overview of Migraine, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

– Detailed information on Calcium channel antagonists including product description, safety and efficacy profiles as well as a SWOT analysis.

– Sales forecast for Calcium channel antagonists for the top two countries from 2012 to 2023.

– Sales information covered for the Italy and Japan.

Reasons to buy

– Understand and capitalize by identifying products that are most likely to ensure a robust return

– Stay ahead of the competition by understanding the changing competitive landscape for Migraine

– Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

– Make more informed business decisions from insightful and in-depth analysis of Calcium channel antagonists performance

– Obtain sales forecast for Calcium channel antagonists from 2012-2023 in the top two countries (Italy and Japan)

For more information visit

  • Personal Investing Ideas & Strategies
  • Health
  • Calcium channel antagonists

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Did you find this useful? More Info:


    Download your FREE Report on Headache


    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache


    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.


    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!